Description:
The global COVID-19 pandemic has profoundly transformed the diagnostic industry, creating an unprecedented demand for test products and leading to significant market growth. Kalorama Information’s COVID-19 Testing Update, 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends report offers an in-depth analysis of this rapidly evolving market, focusing on molecular, antigen, and antibody tests.
Key Features of the Report:
- Market Impact: Analysis of how COVID-19 has reshaped the in vitro diagnostic (IVD) market, including revenue increases, company expansions, and the launch of new products.
- Technological Advancements: New features in test products such as variant and mutation detection, combination testing with flu and RSV, more specific antibody detection, and ultra-large volume capacities.
Scope of the Report:
- Disease Overview: Progress, trends, and developments in COVID-19.
- Mutations: Impact of SARS-CoV-2 variants on testing.
- Home Testing: Rise and potential of at-home COVID-19 tests.
- Market Data:
- COVID-19 Antigen Tests (2020 and 2021)
- COVID-19 Molecular Tests (2020 and 2021)
- COVID-19 Antibody Tests (2020 and 2021)
- Market breakdown by geography (US, Europe, Asia, Rest of World)
- Product Listings:
- Antigen Products
- PCR and Other Molecular Products
- Regulatory Updates: FDA Emergency Authorized Tests (Molecular, Antigen, and Antibody)
- Vaccine Impact: Analysis of the effects of vaccination on the testing market.
Competitive Analysis:
- New Entrants: Companies entering the diagnostics market due to the pandemic.
- Major IVD Players: Impact of COVID-19 on their performance, including expansions, acquisitions, and new product launches.
Key Trends Examined:
- Biden Administration Plans: Impact of government spending on the test markets.
- Home Testing: Growth of at-home testing beyond glucose, ovulation, and low-volume infectious tests.
- Mutations: Analysis of SARS-CoV-2 mutations and their implications for diagnostics.
- Vaccines: Examination of how widespread vaccination affects the demand for COVID-19 tests.
- Endemic Status: Potential for COVID-19 to become an endemic virus with recurring outbreaks.
- Supply Shortages: Challenges in the supply chain for molecular testing and implications for future testing.
- Larger Test Volumes: Lasting changes in lab medicine due to increased test volumes.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Regional Breakout of COVID-19 Testing Market, 2020-2021 ($ millions)
| Item/Year | 2020 | 2021 | % Change |
| North America | $XX Millions | $XX Millions | XX% |
| Europe | $XX Millions | $XX Millions | XX% |
| APAC | $XX Millions | $XX Millions | XX% |
| LATAM | $XX Millions | $XX Millions | XX% |
| ROW | $XX Millions | $XX Millions | XX% |
| Total | $XX Millions | $XX Millions | XX% |
Source: Kalorama Information
